These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1527785)

  • 21. Imidazo[1,2-a]pyrazine, Imidazo[1,5-a]quinoxaline and Pyrazolo[1,5-a]quinoxaline derivatives as IKK1 and IKK2 inhibitors.
    Patinote C; Bou Karroum N; Moarbess G; Deleuze-Masquefa C; Hadj-Kaddour K; Cuq P; Diab-Assaf M; Kassab I; Bonnet PA
    Eur J Med Chem; 2017 Sep; 138():909-919. PubMed ID: 28750313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted 6,7-dihydroimidazo[1,2-a]purin-9(4H)-ones.
    Temple DL; Yevich JP; Catt JD; Owens D; Hanning C; Covington RR; Seidehamel RJ; Dungan KW
    J Med Chem; 1980 Nov; 23(11):1188-98. PubMed ID: 6161252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and hypoglycemic activity of substituted 8-(1-piperazinyl)imidazo[1,2-a]pyrazines.
    Meurer LC; Tolman RL; Chapin EW; Saperstein R; Vicario PP; Zrada MM; MacCoss M
    J Med Chem; 1992 Oct; 35(21):3845-57. PubMed ID: 1359141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, antileishmanial activity and cytotoxicity of 2,3-diaryl- and 2,3,8-trisubstituted imidazo[1,2-a]pyrazines.
    Marchand P; Bazin MA; Pagniez F; Rivière G; Bodero L; Marhadour S; Nourrisson MR; Picot C; Ruchaud S; Bach S; Baratte B; Sauvain M; Pareja DC; Vaisberg AJ; Le Pape P
    Eur J Med Chem; 2015 Oct; 103():381-95. PubMed ID: 26383125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyrazines: the role of nitrogen position in inotropic activity.
    Spitzer WA; Victor F; Pollock GD; Hayes JS
    J Med Chem; 1988 Aug; 31(8):1590-5. PubMed ID: 3397997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potency switch between CHK1 and MK2: discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors.
    Meng Z; Ciavarri JP; McRiner A; Zhao Y; Zhao L; Reddy PA; Zhang X; Fischmann TO; Whitehurst C; Arshad Siddiqui M
    Bioorg Med Chem Lett; 2013 May; 23(10):2863-7. PubMed ID: 23587425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent advances in development of imidazo[1,2-a]pyrazines: synthesis, reactivity and their biological applications.
    Goel R; Luxami V; Paul K
    Org Biomol Chem; 2015 Mar; 13(12):3525-55. PubMed ID: 25563506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of new 8-anilide theophylline derivatives as bronchodilators and antibacterial agents.
    Hayallah AK; Talhouni AA; Alim AA
    Arch Pharm Res; 2012 Aug; 35(8):1355-68. PubMed ID: 22941478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors.
    Mulvihill MJ; Ji QS; Coate HR; Cooke A; Dong H; Feng L; Foreman K; Rosenfeld-Franklin M; Honda A; Mak G; Mulvihill KM; Nigro AI; O'Connor M; Pirrit C; Steinig AG; Siu K; Stolz KM; Sun Y; Tavares PA; Yao Y; Gibson NW
    Bioorg Med Chem; 2008 Feb; 16(3):1359-75. PubMed ID: 17983756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigation into the role of phosphodiesterase IV in bronchorelaxation, including studies with human bronchus.
    Cortijo J; Bou J; Beleta J; Cardelús I; Llenas J; Morcillo E; Gristwood RW
    Br J Pharmacol; 1993 Feb; 108(2):562-8. PubMed ID: 8383567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New beta-diketone and 3,5-dimethyl isoxazole derivatives of theophylline as potential bronchodilator agents.
    Akgün H; Balkan A; Erol K; Batu OS
    Arzneimittelforschung; 1998 Jun; 48(6):658-62. PubMed ID: 9689423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, evaluation and structure-activity relationships of 5-alkyl-2,3-dihydroimidazo[1,2-c] quinazoline, 2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-thiones and their oxo-analogues as new potential bronchodilators.
    Bahekar RH; Rao AR
    Arzneimittelforschung; 2001; 51(4):284-92. PubMed ID: 11367868
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and preliminary pharmacological screening of novel imidazo[2,1-f]theophylline derivatives.
    Pawłowski M; Katlabi J; Jurczyk S; Malec D; Modzelewski J
    Farmaco; 2002 Sep; 57(9):697-702. PubMed ID: 12385518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of the megakaryoblastic Dami cell line differentiation by phosphodiesterase inhibitors and imidazo[1,2-a]pyrazine derivatives.
    Zurbonsen K; Michel A; Vittet D; Bonnet PA; Chevillard C
    Pharmacol Toxicol; 1997 Jun; 80(6):286-9. PubMed ID: 9225365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of some new theophylline derivatives with bronchodilator and antibacterial activities.
    Hayallah AM; Elgaher WA; Salem OI; Alim AA
    Arch Pharm Res; 2011 Jan; 34(1):3-21. PubMed ID: 21468910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anticancer activity of oxindole derived imidazo[1,5-a]pyrazines.
    Kamal A; Ramakrishna G; Raju P; Rao AV; Viswanath A; Nayak VL; Ramakrishna S
    Eur J Med Chem; 2011 Jun; 46(6):2427-35. PubMed ID: 21481986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 2- and 3-substituted imidazo[1,2-a]pyrazines as inhibitors of bacterial type IV secretion.
    Sayer JR; Walldén K; Pesnot T; Campbell F; Gane PJ; Simone M; Koss H; Buelens F; Boyle TP; Selwood DL; Waksman G; Tabor AB
    Bioorg Med Chem; 2014 Nov; 22(22):6459-70. PubMed ID: 25438770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors.
    Zheng P; Zhang J; Ma H; Yuan X; Chen P; Zhou J; Zhang H
    Bioorg Med Chem; 2019 Apr; 27(7):1391-1404. PubMed ID: 30824168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479.
    Robarge KD; Lee W; Eigenbrot C; Ultsch M; Wiesmann C; Heald R; Price S; Hewitt J; Jackson P; Savy P; Burton B; Choo EF; Pang J; Boggs J; Yang A; Yang X; Baumgardner M
    Bioorg Med Chem Lett; 2014 Oct; 24(19):4714-4723. PubMed ID: 25193232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aurora kinase inhibitors based on the imidazo[1,2-a]pyrazine core: fluorine and deuterium incorporation improve oral absorption and exposure.
    Kerekes AD; Esposite SJ; Doll RJ; Tagat JR; Yu T; Xiao Y; Zhang Y; Prelusky DB; Tevar S; Gray K; Terracina GA; Lee S; Jones J; Liu M; Basso AD; Smith EB
    J Med Chem; 2011 Jan; 54(1):201-10. PubMed ID: 21128646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.